Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ALTERITY THERAPEUTICS LTD (ATHE)

$4.54 -3.20% NASDAQ: ATHE · 15-min delayed
  • Public · NASDAQ: ATHE
  • 9 employees
$70.7MMarket cap
9Employees
ATHENASDAQ
1992IPO

About ALTERITY THERAPEUTICS LTD

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$70.7M
NASDAQ: ATHE
$4.54 -3.20%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.92 $6.55

52-week range

Market cap
$70.7M
Shares outstanding
15.6M
Open
Day range
Prev close
Volume
IPO date
Mar 4, 1992

Alterity Therapeutics Ltd (ATHE) Stock Price

  • Trading 31% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ALTERITY THERAPEUTICS LTD.

Write a review
Newsroom

News about ALTERITY THERAPEUTICS LTD

News & sentiment via Polygon.io

FAQ

Alterity Therapeutics Ltd: frequently asked questions

Is Alterity Therapeutics Ltd an American company?

Alterity Therapeutics Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Alterity Therapeutics Ltd publicly traded?

Yes — Alterity Therapeutics Ltd is a publicly traded company. Its stock trades under the ticker symbol ATHE on the NASDAQ.

What does Alterity Therapeutics Ltd do?

Alterity Therapeutics Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →